Outcomes of Patients Receiving Temporary Circulatory Support Before Durable Ventricular Assist Device Palak Shah, MD, MS, Francis D. Pagani, MD, PhD,

Slides:

Advertisements

Similar presentations

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Advertisements

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Jennifer A. Cowger, MD, Matthew A

What Predicts Long-Term Survival After Heart Transplantation

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Benny Weksler, MD, Jennifer L. Sullivan, MD

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD,

Trevor Williams, MD, MPH, Brian C

Pump Replacement for Left Ventricular Assist Device Failure Can Be Done Safely and Is Associated With Low Mortality Nader Moazami, MD, Carmelo A. Milano,

Laura Harvey, MD, Christopher Holley, MD, Samit S

Dhaval Chauhan, MD, Alexis K

Continuous Flow Left Ventricular Assist Device Outcomes in Commercial Use Compared With the Prior Clinical Trial Ranjit John, MD, Yoshifumi Naka, MD,

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Bi-Ventricular Circulatory Support With the Abiomed AB5000 System in a Patient With Idiopathic Refractory Ventricular Fibrillation Li Zhang, MD, MS,

John D. Rutkoski, MD, Beth A. Schrope, MD, Benjamin E. Lee, MD

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis Naoto Morimoto,

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Mitral Valve Repair Is Durable in Patients With Rheumatoid Arthritis

Operative Results and Outcomes in Children With Shone's Anomaly

Loretta Erhunmwunsee, MD, Brian C

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Javed Butler, MD, Carrie Geisberg, MD, Renee Howser, MSN, Peer M

Bahaaldin Alsoufi, MD, Sally Cai, PhD, Glen S

FDA Perspective on Clinical Trial Design for Cardiovascular Devices

Age-Related Outcomes of the Ross Procedure Over 20 Years

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Trevor Williams, MD, MPH, Brian C

Surgical Resection of Rare Esophageal Cancers

Origins of the Cardiothoracic Surgery Network (CTSNet)

Who Do You Say You Are? The Annals of Thoracic Surgery

Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle Masashi Kawabori, MD, Chitaru Kurihara, MD, Tadahisa.

Use of Amiodarone After Major Lung Resection

Left Ventricular Assist Device Inflow Angle and Pump Positional Change Over Time Adverse Impact on Left Ventricular Assist Device Function Toshinobu.

Adverse events in contemporary continuous-flow left ventricular assist devices: A multi- institutional comparison shows significant differences John M.

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Nicholas A. Haglund, MD, Mary E. Davis, MS, CCRP, Nicole M

Determinants of Left Ventricular Dysfunction After Repair of Chronic Asymptomatic Mitral Regurgitation Vincent Chan, MD, MPH, Marc Ruel, MD, MPH, Elsayed.

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Infective Endocarditis With Paravalvular Extension: 35-Year Experience

Neurofibromatosis of the Esophagus

Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Erik N. Sorensen, PhD, Richard N. Pierson, MD, Erika D

Editorial Board, January 2010

Sarah C. Huen, MD, Chirag R. Parikh, MD, PhD

William M. Whited, MD, Paul Henley, BS, Erin M

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Pretransplant Panel Reactive Antibodies in Human Lung Transplantation: An Analysis of Over 10,000 Patients Ashish S. Shah, MD, Lois Nwakanma, MD, Christopher.

Mechanical Circulatory Support and Heart Transplantation: Donor and Recipient Factors Influencing Graft Survival Simon Maltais, MD, PhD, Nikhil P. Jaik,

Single Versus Double Lung Retransplantation Does Not Affect Survival Based on Previous Transplant Type Erin M. Schumer, MD, MPH, Jonathan D. Rice, MD,

Specialty Training and Mortality After Esophageal Cancer Resection

The Additional Prognostic Value of Left Atrial Volume on the Outcome of Patients After Surgical Ventricular Reconstruction Serenella Castelvecchio, MD,

Dana Y. Fuhrman, DO, MS, Lan G

Invited Commentary The Annals of Thoracic Surgery

Functional and Physiologic Results of Video-Assisted Thoracoscopic Diaphragm Plication in Adult Patients With Unilateral Diaphragm Paralysis Richard.

“Prophylactic” Tricuspid Repair for Functional Tricuspid Regurgitation

The American Board of Thoracic Surgery: Update

Late Aortic Insufficiency Related to Poor Prognosis During Left Ventricular Assist Device Support Koichi Toda, MD, PhD, Tomoyuki Fujita, MD, Keitaro.

Reoperation for Coronary Artery Bypass Grafting Surgery: Outcomes and Considerations for Expanding Interventional Procedures Simon Maltais, MD, PhD,

Late Consequences of a Much Earlier Decision

Justin P. V. Zachariah, MD, Frank A. Pigula, MD, John E

The Impact of New Technology on Cardiothoracic Surgical Practice

John R. Handy, MD, HonD, Kelly Denniston, RHIT, Gary L

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Significance of Postoperative Acute Renal Failure After Continuous-Flow Left Ventricular Assist Device Implantation Jamil Borgi, MD, Athanasios Tsiouris,

Repair of Left Ventricular Inflow Tract Lesions in Shone's Anomaly: Valve Growth and Long-Term Outcome Eva Maria B. Delmo Walter, MD, PhD, Richard Van.

Presentation transcript:

Outcomes of Patients Receiving Temporary Circulatory Support Before Durable Ventricular Assist Device Palak Shah, MD, MS, Francis D. Pagani, MD, PhD, Shashank S. Desai, MD, Anthony J. Rongione, MD, Simon Maltais, MD, PhD, Nicholas A. Haglund, MD, Shannon M. Dunlay, MD, MS, Keith D. Aaronson, MD, MS, John M. Stulak, MD, PhD, Mary Beth Davis, MS, Christopher T. Salerno, MD, Jennifer A. Cowger, MD, MS The Annals of Thoracic Surgery Volume 103, Issue 1, Pages 106-112 (January 2017) DOI: 10.1016/j.athoracsur.2016.06.002 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Overall stratified patient survival: temporary circulatory support (TCS) patients (blue line); profile 1 patients (green line); and profile 2 and 3 patients (chartreuse line). The Annals of Thoracic Surgery 2017 103, 106-112DOI: (10.1016/j.athoracsur.2016.06.002) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions